Navigation Links
Ahram Biosystems Completes Development of a Palm-Size Portable PCR Device
Date:6/17/2008

New instrument system delivers highly efficient and fast PCR amplification

in a fully portable format

SAN DIEGO, June 17 /PRNewswire/ -- Ahram Biosystems, Inc., a leading developer of state-of-the-art PCR devices and Cell-based assay systems, today announced at the BIO 2008 Annual International Convention at the San Diego Convention Center that it has successfully completed development of Palm PCR, a palm-size portable thermocycler capable of delivering PCR amplified product in as little as 15 minutes. This device features the smallest size of all the PCR devices on the market.

"We are very excited to introduce our novel and truly hand-held portable PCR device as it provides not only the fastest amplification but is highly efficient with a wide dynamic range, yet adapting the standard 9 mm-spaced well format with a disposable plastic tube," said Dr. Hyun Jin Hwang, Ahram's Chairman and CEO.

"The ability to achieve rapid PCR amplification in a fully portable format will not only enable researchers to perform conventional laboratory experiments more effectively, but will also significantly ease other downstream applications such as those requiring in-situ or on-site genomic detection," said Dr. Jane Kim, Ahram's CSO.

Palm PCR is a battery-powered stand-alone portable thermocycler designed for simplicity and robustness. In spite of its very small size, this powerful device delivers highly efficient and fast amplification for nearly all kinds of DNA samples including the human genome. Even a single copy of DNA can be amplified in as little as 25 minutes to an amount sufficient for typical agarose-gel detection. The system provides both new and experienced researchers with a highly-functional and easy-to-use way to conduct various PCR experiments. "It has the lowest power consumption of all the commercially available thermocyclers (< 5 watts) to date, is capable of achieving uniformity better than +/- 0.1 degrees C and can run for more than 4 hours on a single charge of a Li-ion battery," added Dr. Hwang.

Ahram Biosystems is located at booth # 4142 in the BIO exhibition hall.

About Ahram Biosystems:

Ahram Biosystems, Inc. is a privately held biotechnology company based in Seoul, Korea that develops and commercializes innovative portable high-speed PCR devices and Cell-based assay systems. Founded in 2001, the company globally employs approximately 20 professionals in South Korea and USA. For more information, visit http://www.ahrambio.com.


'/>"/>
SOURCE Ahram Biosystems, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ImaRx Therapeutics Signs Letter of Intent With Microbix Biosystems for the Sale of Urokinase
2. Open Biosystems Open Access RNAi Program Adopted by University of Copenhagen and University of Queensland
3. Altogen Biosystems Launches Custom Biotechnology Research Services: Generation of Stable Cell Lines and RNAi Cell Transfection Services
4. Open Biosystems Open Access RNAi Program Adopted by Harvard Medical School and University of North Carolina
5. Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagents
6. Microfluidic Systems Announces Agreements With Applied Biosystems and United Technologies Hamilton Sundstrand Division for Production of Bioagent Autonomous Networked Detector System
7. Primera Biosystems Raises $21 Million in Series B Private Round
8. Sigma-Aldrich and Oxford BioMedica Win Key Ruling in Open Biosystems Patent Infringement Dispute
9. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
10. China Sun Group High-Tech Co. Completes Share Exchange to Create 100% Ownership in DLX Subsidiary
11. EnzySurge, Maker of DermaStream(TM), Completes Funding Round of US$4 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... The Board ... the appointment of John Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven ... the founding commercial leaders responsible for the commercialization of multiple orphan drug indications. ...
(Date:4/27/2016)... MIAMI (PRWEB) , ... April 27, 2016 , ... ... a mutual endorsement of an Asia-Pacific Symposium as other research and development initiatives for ... of Santiago officials and top Global Stem Cells Group executives began meeting to establish ...
(Date:4/26/2016)... ... ... The European Patent Office (EPO) today announced that U.S. Biophysicist ... Inventor Award 2016 in the category "Non-European countries." The winners of the 11th edition ... on June 9th. , The human capacity to walk with fluidity is the sum ...
(Date:4/26/2016)... ... April 26, 2016 , ... Seattle based non-profit, The ... from 1Plus12 Corporation. The grant will be used to further the scientific research ... organization's website http://www.ivsci.org , In accounting the grant to the IVS, ...
Breaking Biology Technology:
(Date:3/14/2016)... NXTD ) ("NXT-ID" or the "Company"), a company ... of a new series of commercials on Time Warner Cable ... .  The commercials will air on Bloomberg TV, Fox Business ... show. --> NXTD ) ("NXT-ID" or the "Company"), ... the airing of a new series of commercials on Time ...
(Date:3/10/2016)... , March 10, 2016 ... new market research report "Identity and Access Management Market ... Audit, Compliance, and Governance), by Organization Size, by Deployment, ... 2020", published by MarketsandMarkets, The market is estimated to ... 12.78 Billion by 2020, at a Compound Annual Growth ...
(Date:3/9/2016)... GARDENS, Fla. , March 9, 2016 /PRNewswire/ ... management authentication and enrollment solutions, today announced the ... DigitalPersona ® Altus multi-factor authentication platform. ... and InfoSec managers to step-up security where it,s ... Washington, DC . ...
Breaking Biology News(10 mins):